SCHEMBL18266303

SCHEMBL18266303

Cc1cc(C(=O)NCc2ccc(F)c(OC(C)(F)F)c2)cc(NC(=O)C(C)C)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.47
KCNB1 Q14721 1/20 0.39
RIPK1 Q13546 2/20 0.39
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38
MMP13 P45452 2/20 0.38
MAPT P10636 1/20 0.37
GSK3B P49841 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
EPHX2 P34913 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
HSD17B10 Q99714 1/20 0.36
CTSD P07339 1/20 0.36
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
CHRM4 P08173 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2715396 0.94 SCN9A (0.48) SCN9AKCNB1RIPK1ROCK2ROCK1
SCHEMBL18266320 0.88 ADORA3 (0.39) SCN9ARIPK1ROCK2ROCK1MMP13
SCHEMBL18266538 0.87 KCNB1 (0.50) SCN9AKCNB1RIPK1ROCK2ROCK1
SCHEMBL2713199 0.86 SCN9A (0.48) SCN9AKCNB1RIPK1ROCK2CHRM4
SCHEMBL18266345 0.86 SCN9A (0.48) SCN9ARIPK1PPARGPPARDPPARA
SCHEMBL2714077 0.85 SCN9A (0.50) SCN9AMMP13HSD17B10PPARDPPARA
SCHEMBL2714516 0.84 SCN9A (0.49) SCN9AKCNB1RIPK1ROCK2EPHX2
SCHEMBL18266341 0.84 SCN9A (0.47) SCN9AKCNB1RIPK1MAPTGSK3B
SCHEMBL18266426 0.83 SCN9A (0.49) SCN9AKCNB1ROCK2ROCK1MAPT
SCHEMBL2714499 0.83 RIPK1 (0.51) RIPK1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2630122-B1 ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS RAQUALIA PHARMA INC (JP) 2016-11-30 EP disclosed